[Form 4] Inspire Veterinary Partners, Inc. Insider Trading Activity
Charles Stith Keiser, a director of Inspire Veterinary Partners, Inc. (IVP), reported exercising stock options on 09/26/2024 to acquire 953 shares of Class A Common Stock at an exercise price of $17 per share. The transaction is reported as a direct acquisition and the Form 4 notes that the share amounts have been adjusted for a 25-for-1 reverse stock split effected by the issuer on January 27, 2025. The filing states it was submitted late due to an inadvertent administrative error and is signed by Mr. Keiser on 08/07/2025.
Charles Stith Keiser, amministratore di Inspire Veterinary Partners, Inc. (IVP), ha comunicato di aver esercitato opzioni su azioni il 26/09/2024 per acquisire 953 azioni di Azioni Ordinarie di Classe A a un prezzo di esercizio di $17 per azione. L'operazione 猫 riportata come acquisizione diretta e il Modulo 4 specifica che le quantit脿 di azioni sono state adeguate in seguito a uno split inverso 25-contro-1 effettuato dall'emittente il 27 gennaio 2025. Il deposito indica che 猫 stato inviato in ritardo a causa di un errore amministrativo involontario ed 猫 firmato da Mr. Keiser il 07/08/2025.
Charles Stith Keiser, director de Inspire Veterinary Partners, Inc. (IVP), inform贸 haber ejercido opciones sobre acciones el 26/09/2024 para adquirir 953 acciones de acciones ordinarias Clase A a un precio de ejercicio de $17 por acci贸n. La transacci贸n se declara como una adquisici贸n directa y el Formulario 4 indica que los importes de acciones se han ajustado por una consolidaci贸n inversa de 25 a 1 llevada a cabo por el emisor el 27 de enero de 2025. La presentaci贸n se帽ala que se envi贸 tarde debido a un error administrativo involuntario y est谩 firmada por el Sr. Keiser el 07/08/2025.
Charles Stith Keiser, Inspire Veterinary Partners, Inc.(IVP)鞚� 鞚挫偓搿滌劀, 2024-09-26鞐� 欤检嫕 毵れ垬靹犿儩甓岇潉 頄夓偓頃橃棳 氤错喌欤� 韥措灅鞀� A 953欤�毳� 欤茧嫻 $17鞚� 頄夓偓臧�搿� 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. 瓯半灅電� 歆侅爲 旆摑鞙茧 氤搓碃霅橃棃鞙茧┌, Form 4鞐愲姅 氚滍枆鞚胳澊 2025雲� 1鞗� 27鞚检棎 鞁滍枆頃� 25雽�1 鞎‰┐氤戫暕(鞐硲頃�)鞐� 霐半澕 欤检嫕 靾橁皜 臁办爼霅橃棃鞚岇澊 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊電� 鞁れ垬搿� 鞚疙暅 頄夓爼鞝� 鞓る搿� 電﹃矊 鞝滌稖霅橃棃鞙茧┌ Mr. Keiser臧� 2025-08-07鞐� 靹滊獏頃� 瓴冹溂搿� 霅橃柎 鞛堨姷雼堧嫟.
Charles Stith Keiser, administrateur d'Inspire Veterinary Partners, Inc. (IVP), a d茅clar茅 avoir exerc茅 des options d'achat d'actions le 26/09/2024 pour acqu茅rir 953 actions de capital social de cat茅gorie A au prix d'exercice de 17 $ par action. La transaction est signal茅e comme une acquisition directe et le Formulaire 4 pr茅cise que les montants d'actions ont 茅t茅 ajust茅s suite 脿 une consolidation invers茅e de 25 pour 1 effectu茅e par l'茅metteur le 27 janvier 2025. Le d茅p么t indique qu'il a 茅t茅 soumis en retard en raison d'une erreur administrative involontaire et est sign茅 par M. Keiser le 07/08/2025.
Charles Stith Keiser, ein Direktor von Inspire Veterinary Partners, Inc. (IVP), meldete, dass er am 26.09.2024 Aktienoptionen ausge眉bt hat, um 953 Aktien der Klasse A Stammaktien zu einem Aus眉bungspreis von $17 je Aktie zu erwerben. Die Transaktion wird als direkte Erwerbung angegeben und im Formular 4 wird vermerkt, dass die Aktienanzahlen aufgrund einer vom Emittenten am 27. Januar 2025 诲耻谤肠丑驳别蹿眉丑谤迟别苍 25-zu-1 Reverse-Split-Anpassung bereinigt wurden. Die Einreichung erkl盲rt, sie sei aufgrund eines versehentlichen administrativen Fehlers versp盲tet eingereicht worden und wurde von Herrn Keiser am 07.08.2025 unterschrieben.
- Director exercised options and increased direct ownership by 953 shares, signaling personal investment in the company.
- Form discloses adjustment for a 25:1 reverse stock split, clarifying post-split share counts.
- Form 4 was filed late, attributed to an "inadvertent administrative error," which raises a disclosure-timeliness concern.
Insights
TL;DR Insider exercised options to buy 953 shares at $17; filing late but disclosure corrected.
The reported exercise of options by a director indicates continued personal investment in the company, transforming vested derivative rights into 953 shares held directly. The adjustment for a 25:1 reverse split is disclosed, clarifying post-split share counts. The late filing is labeled an administrative error; while remedied, late Section 16 reporting can raise short-term governance or compliance questions for investors monitoring disclosure timeliness. The absolute size of the holdings appears small relative to typical institutional thresholds, suggesting limited market impact.
TL;DR Director converted options into common stock; corrective disclosure filed after reverse split adjustment.
From a governance perspective, the form shows routine insider option exercise and proper identification of ownership form as direct. The explanation of the reverse split shows attention to accurate share reporting post-capital-action. The admission of a late filing for administrative reasons is appropriate disclosure; however, recurrent delays could indicate weaknesses in reporting controls. Based solely on this single Form 4, the event is procedural rather than a material corporate governance shift.
Charles Stith Keiser, amministratore di Inspire Veterinary Partners, Inc. (IVP), ha comunicato di aver esercitato opzioni su azioni il 26/09/2024 per acquisire 953 azioni di Azioni Ordinarie di Classe A a un prezzo di esercizio di $17 per azione. L'operazione 猫 riportata come acquisizione diretta e il Modulo 4 specifica che le quantit脿 di azioni sono state adeguate in seguito a uno split inverso 25-contro-1 effettuato dall'emittente il 27 gennaio 2025. Il deposito indica che 猫 stato inviato in ritardo a causa di un errore amministrativo involontario ed 猫 firmato da Mr. Keiser il 07/08/2025.
Charles Stith Keiser, director de Inspire Veterinary Partners, Inc. (IVP), inform贸 haber ejercido opciones sobre acciones el 26/09/2024 para adquirir 953 acciones de acciones ordinarias Clase A a un precio de ejercicio de $17 por acci贸n. La transacci贸n se declara como una adquisici贸n directa y el Formulario 4 indica que los importes de acciones se han ajustado por una consolidaci贸n inversa de 25 a 1 llevada a cabo por el emisor el 27 de enero de 2025. La presentaci贸n se帽ala que se envi贸 tarde debido a un error administrativo involuntario y est谩 firmada por el Sr. Keiser el 07/08/2025.
Charles Stith Keiser, Inspire Veterinary Partners, Inc.(IVP)鞚� 鞚挫偓搿滌劀, 2024-09-26鞐� 欤检嫕 毵れ垬靹犿儩甓岇潉 頄夓偓頃橃棳 氤错喌欤� 韥措灅鞀� A 953欤�毳� 欤茧嫻 $17鞚� 頄夓偓臧�搿� 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. 瓯半灅電� 歆侅爲 旆摑鞙茧 氤搓碃霅橃棃鞙茧┌, Form 4鞐愲姅 氚滍枆鞚胳澊 2025雲� 1鞗� 27鞚检棎 鞁滍枆頃� 25雽�1 鞎‰┐氤戫暕(鞐硲頃�)鞐� 霐半澕 欤检嫕 靾橁皜 臁办爼霅橃棃鞚岇澊 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊電� 鞁れ垬搿� 鞚疙暅 頄夓爼鞝� 鞓る搿� 電﹃矊 鞝滌稖霅橃棃鞙茧┌ Mr. Keiser臧� 2025-08-07鞐� 靹滊獏頃� 瓴冹溂搿� 霅橃柎 鞛堨姷雼堧嫟.
Charles Stith Keiser, administrateur d'Inspire Veterinary Partners, Inc. (IVP), a d茅clar茅 avoir exerc茅 des options d'achat d'actions le 26/09/2024 pour acqu茅rir 953 actions de capital social de cat茅gorie A au prix d'exercice de 17 $ par action. La transaction est signal茅e comme une acquisition directe et le Formulaire 4 pr茅cise que les montants d'actions ont 茅t茅 ajust茅s suite 脿 une consolidation invers茅e de 25 pour 1 effectu茅e par l'茅metteur le 27 janvier 2025. Le d茅p么t indique qu'il a 茅t茅 soumis en retard en raison d'une erreur administrative involontaire et est sign茅 par M. Keiser le 07/08/2025.
Charles Stith Keiser, ein Direktor von Inspire Veterinary Partners, Inc. (IVP), meldete, dass er am 26.09.2024 Aktienoptionen ausge眉bt hat, um 953 Aktien der Klasse A Stammaktien zu einem Aus眉bungspreis von $17 je Aktie zu erwerben. Die Transaktion wird als direkte Erwerbung angegeben und im Formular 4 wird vermerkt, dass die Aktienanzahlen aufgrund einer vom Emittenten am 27. Januar 2025 诲耻谤肠丑驳别蹿眉丑谤迟别苍 25-zu-1 Reverse-Split-Anpassung bereinigt wurden. Die Einreichung erkl盲rt, sie sei aufgrund eines versehentlichen administrativen Fehlers versp盲tet eingereicht worden und wurde von Herrn Keiser am 07.08.2025 unterschrieben.
FAQ
What insider transaction was reported for IVP?
How is ownership reported after the transaction for IVP?
Was there any corporate action affecting share counts for IVP?
Was the Form 4 filed on time for IVP?
When was the Form 4 signed?
